Immune-related adverse events: a retrospective look into the future of oncology in the intensive care unit.
Adrien JosephAudrey SimonaggioAnnabelle StoclinAntoine Vieillard-BaronGuillaume GeriStéphane OudardJean-Marie MichotOlivier LambotteElie AzoulayVirginie LemialePublished in: Annals of intensive care (2020)
Admission to the intensive care unit related to immune-related adverse event was associated with better outcome in cancer patients treated with immune checkpoint inhibitors. Our results support the admission for an intensive care unit trial for patients with suspected immune-related adverse events.